EU regulators back Pfizer's updated vaccine for dominant Omicron subvariant
The vaccine is to be used for preventing Covid-19 in adults and children with a dosage dependent on previous vaccinations.
Pfizer considers cost cuts as demand for Covid products falls
If Covid vaccinations are very low this year, the company will scale back its investments for the virus, including combination shots, as part of its cost plan.
No stroke cases reported for Pfizer bivalent vaccine in clinical studies, says health DG
Dr Noor Hisham Abdullah says the National Pharmaceutical Regulatory Agency will keep tabs on data and analysis on the use of the vaccine, which has yet to be deployed in Malaysia.
US health authorities see early signal of possible stroke link with Pfizer bivalent Covid shot
The CDC and FDA say the matter requires more investigation.
China in talks with Pfizer for generic Covid drug, sources say
China's medical products regulator — the National Medical Products Administration — is said to have been leading the talks with Pfizer since late last month.
Pfizer expects to hike US Covid vaccine price to US$110-US$130 per dose
The vaccine – currently provided for free to all by the government – is expected to be made available at no cost to people who have private insurance or government paid insurance.
US cutting global donations of Pfizer Covid shots as demand slows
Pfizer says it has already delivered 400 million vaccine doses in 79 countries under the US government contract.
Pfizer donates Paxlovid to group targeting Covid in poorer countries
While Paxlovid is widely available in many rich countries, availability has been severely restricted in poorer ones, echoing the disparities in the global Covid-19 response.
Moderna sues Pfizer-BioNTech for patent infringement over Covid vaccine
It accuses them of copying technology that Moderna developed years before the pandemic.
Ombudsman says missing EU-Pfizer vaccine deal texts a 'wake-up call'
The ombudsman says consequential instant messages should be recognised as EU documents falling under transparency rules, recorded and made available for freedom of information requests.
Pfizer-BioNTech say Omicron-based Covid shots improve variant-specific response
Advisers to the US Food and Drug Administration are scheduled to meet on Tuesday to discuss whether to update Covid-19 vaccines for the fall.
Pfizer Covid vaccine for under-fives effective with three doses
An analysis of a subset of participants showed antibody levels were similar to 16- to 25-year-olds who were given the full strength vaccine at two doses.
